Cargando…
The COVID-19 pandemic and the use of MS disease-modifying therapies
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138156/ https://www.ncbi.nlm.nih.gov/pubmed/32334820 http://dx.doi.org/10.1016/j.msard.2020.102073 |
| _version_ | 1783518541492781056 |
|---|---|
| author | Giovannoni, Gavin Hawkes, Chris Lechner-Scott, Jeannette Levy, Michael Waubant, Emmanuelle Gold, Julian |
| author_facet | Giovannoni, Gavin Hawkes, Chris Lechner-Scott, Jeannette Levy, Michael Waubant, Emmanuelle Gold, Julian |
| author_sort | Giovannoni, Gavin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7138156 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71381562020-04-07 The COVID-19 pandemic and the use of MS disease-modifying therapies Giovannoni, Gavin Hawkes, Chris Lechner-Scott, Jeannette Levy, Michael Waubant, Emmanuelle Gold, Julian Mult Scler Relat Disord Article Elsevier B.V. 2020-04 2020-03-27 /pmc/articles/PMC7138156/ /pubmed/32334820 http://dx.doi.org/10.1016/j.msard.2020.102073 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Giovannoni, Gavin Hawkes, Chris Lechner-Scott, Jeannette Levy, Michael Waubant, Emmanuelle Gold, Julian The COVID-19 pandemic and the use of MS disease-modifying therapies |
| title | The COVID-19 pandemic and the use of MS disease-modifying therapies |
| title_full | The COVID-19 pandemic and the use of MS disease-modifying therapies |
| title_fullStr | The COVID-19 pandemic and the use of MS disease-modifying therapies |
| title_full_unstemmed | The COVID-19 pandemic and the use of MS disease-modifying therapies |
| title_short | The COVID-19 pandemic and the use of MS disease-modifying therapies |
| title_sort | covid-19 pandemic and the use of ms disease-modifying therapies |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138156/ https://www.ncbi.nlm.nih.gov/pubmed/32334820 http://dx.doi.org/10.1016/j.msard.2020.102073 |
| work_keys_str_mv | AT giovannonigavin thecovid19pandemicandtheuseofmsdiseasemodifyingtherapies AT hawkeschris thecovid19pandemicandtheuseofmsdiseasemodifyingtherapies AT lechnerscottjeannette thecovid19pandemicandtheuseofmsdiseasemodifyingtherapies AT levymichael thecovid19pandemicandtheuseofmsdiseasemodifyingtherapies AT waubantemmanuelle thecovid19pandemicandtheuseofmsdiseasemodifyingtherapies AT goldjulian thecovid19pandemicandtheuseofmsdiseasemodifyingtherapies AT giovannonigavin covid19pandemicandtheuseofmsdiseasemodifyingtherapies AT hawkeschris covid19pandemicandtheuseofmsdiseasemodifyingtherapies AT lechnerscottjeannette covid19pandemicandtheuseofmsdiseasemodifyingtherapies AT levymichael covid19pandemicandtheuseofmsdiseasemodifyingtherapies AT waubantemmanuelle covid19pandemicandtheuseofmsdiseasemodifyingtherapies AT goldjulian covid19pandemicandtheuseofmsdiseasemodifyingtherapies |